NAVXCELL

Live / Registered — Registered (as of 08 Aug 2023)

What this means for you

Registered since 08 Aug 2023. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97436707
Registration number
7134753
Mark type
Stylized text
Filed
31 May 2022
Published for opposition
04 Oct 2022
Registered
08 Aug 2023
Attorney of record
William R. Samuels

Goods and services

  • Class 005 — Pharmaceuticals: Biotechnological platform technology, namely, cell lines for preparation of biological vectors, and recombinant viruses for gene delivery, that includes recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific production of biologics with therapeutic effect in gene therapy, including gene therapy delivery of antibody biologics, enzymes and RNA interference (RNAi)

Owner

Prosecution history

  • 12 Dec 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 12 Dec 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 12 Dec 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 08 Aug 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 08 Aug 2023 — REGISTERED-PRINCIPAL REGISTER
  • 06 Jul 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 05 Jul 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 20 Jun 2023 — STATEMENT OF USE PROCESSING COMPLETE
  • 24 May 2023 — USE AMENDMENT FILED
  • 17 Jun 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 17 Jun 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 17 Jun 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 17 Jun 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 17 Jun 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 17 Jun 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

View this trademark record on Marksy